PAM
CBPO

Princeton Alpha Management’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Princeton Alpha Management’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,258
Closed -$258K – 1073
2016
Q1 		$258K Buy
+2,258
New +$265K 0.04% 559

Other funds holding CBPO

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return
ICP
Indus Capital Partners New York $39.7M AUM 53.95% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Princeton Alpha Management's CBPO Position: Q2 2016 in Review

Princeton Alpha Management sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2016, closing a stake of 2,258 shares — an estimated $258K sold.

Princeton Alpha Management first reported a position in CBPO in Q1 2016 and held it in 1 quarter. The position peaked at $258K in Q1 2016. 138 funds tracked by Wall St. Rank hold CBPO as of Q2 2016.

  • Princeton Alpha Management reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2016 after selling out during the quarter.
  • Princeton Alpha Management sold 2,258 China Biologic Products Holdings, Inc. shares in Q2 2016, an estimated $258K.
  • Princeton Alpha Management first reported a position in China Biologic Products Holdings, Inc. in Q1 2016 and held it in 1 quarter.
  • Princeton Alpha Management's China Biologic Products Holdings, Inc. position peaked at $258K in Q1 2016.
  • 138 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2016.

Based on Princeton Alpha Management's 13F filing for Q2 2016, filed 5 Aug 2016.